282 related articles for article (PubMed ID: 28771722)
1. Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.
Gupta SK; Torrico Guzmán EA; Meenach SA
Int J Cancer; 2017 Nov; 141(10):2143-2153. PubMed ID: 28771722
[TBL] [Abstract][Full Text] [Related]
2. Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics.
Meenach SA; Tsoras AN; McGarry RC; Mansour HM; Hilt JZ; Anderson KW
Int J Oncol; 2016 Apr; 48(4):1701-9. PubMed ID: 26846376
[TBL] [Abstract][Full Text] [Related]
3. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H
Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
[TBL] [Abstract][Full Text] [Related]
4. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
[TBL] [Abstract][Full Text] [Related]
5. Superior intratumoral penetration of paclitaxel nanodots strengthens tumor restriction and metastasis prevention.
Ni D; Ding H; Liu S; Yue H; Bao Y; Wang Z; Su Z; Wei W; Ma G
Small; 2015 Jun; 11(21):2518-26. PubMed ID: 25678130
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic lipid nanovesicles: synergism with paclitaxel in human lung adenocarcinoma A549 cells.
Joshi N; Shanmugam T; Kaviratna A; Banerjee R
J Control Release; 2011 Dec; 156(3):413-20. PubMed ID: 21807043
[TBL] [Abstract][Full Text] [Related]
7. Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
Sha H; Zou Z; Xin K; Bian X; Cai X; Lu W; Chen J; Chen G; Huang L; Blair AM; Cao P; Liu B
J Control Release; 2015 Feb; 200():188-200. PubMed ID: 25553823
[TBL] [Abstract][Full Text] [Related]
8. A tumor-penetrating recombinant protein anti-EGFR-iRGD enhance efficacy of paclitaxel in 3D multicellular spheroids and gastric cancer in vivo.
Sha H; Li R; Bian X; Liu Q; Xie C; Xin X; Kong W; Qian X; Jiang X; Hu W; Liu B
Eur J Pharm Sci; 2015 Sep; 77():60-72. PubMed ID: 25998561
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
Hu C; Chen X; Huang Y; Chen Y
Sci Rep; 2018 Feb; 8(1):2274. PubMed ID: 29396568
[TBL] [Abstract][Full Text] [Related]
12. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
13. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
Solomon MA; Lemera J; D'Souza GG
J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
[TBL] [Abstract][Full Text] [Related]
14. Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids.
Guzmán EAT; Sun Q; Meenach SA
ACS Biomater Sci Eng; 2019 Dec; 5(12):6570-6580. PubMed ID: 32133390
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
Lei H; Hofferberth SC; Liu R; Colby A; Tevis KM; Catalano P; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2015 May; 149(5):1417-24; discussion 1424-25.e1. PubMed ID: 25841659
[TBL] [Abstract][Full Text] [Related]
16. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
[TBL] [Abstract][Full Text] [Related]
17. Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells.
Tian X; Zhang H; Zhang B; Zhao J; Li T; Zhao Y
Oncol Rep; 2017 Jul; 38(1):293-300. PubMed ID: 28586074
[TBL] [Abstract][Full Text] [Related]
18. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.
Yuan H; Sun B; Gao F; Lan M
Pharm Biol; 2016 Nov; 54(11):2629-2635. PubMed ID: 27159496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]